Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001649904-26-000009

EVP, Head of North America sold 75,834 shares at $117.38 ($8,901,531)

  • EVP, Head of North America acquired 56,601 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lee Jennifer Kayden EVP, Head of North America 2026-08-13 Option exercise 10b5-1 +35,000 $24.29 $850,150 54,233 D
Lee Jennifer Kayden EVP, Head of North America 2026-08-13 Option exercise 10b5-1 +21,601 $6.80 $146,887 75,834 D
Lee Jennifer Kayden EVP, Head of North America 2026-08-13 Sale 10b5-1 −75,834 $117.38 $8,901,531 0 D
Derivatives
Lee Jennifer Kayden EVP, Head of North America 2026-08-13 Option exercise · Stock Options (Right to Buy) 10b5-1 −35,000 36,283 D
Lee Jennifer Kayden EVP, Head of North America 2026-08-13 Option exercise · Stock Options (Right to Buy) 10b5-1 −21,601 0 D
Open-market sales · 75,834 sh · avg $117.38 · $8,901,531
Loading xslF345X06/form4.xml…